Jump to content

Talk:CureVac

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by VerenaLauterbach CureVacAG (talk | contribs) at 14:42, 8 May 2018 (Request edit on 8 May 2018). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

WikiProject iconArticles for creation Stub‑class
WikiProject iconThis article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information.
StubThis article has been rated as Stub-class on Wikipedia's content assessment scale.
Note icon
This article was accepted on 25 April 2013 by reviewer Arthur goes shopping (talk · contribs).

Request edit on 8 May 2018

I would like to request the following change: CureVac has entered into a collaboration with Eli Lilly and Company in October 2017. This could be included in the list of partners at the beginning of the entry as well as in the history part. Neutral sources are e.g. https://endpts.com/eli-lilly-is-making-a-1-8b-leap-into-the-mrna-field-targeting-next-gen-cancer-vaccines/ and https://www.fiercebiotech.com/biotech/lilly-curevac-pen-1-8b-mrna-cancer-vaccine-deal Thank you for reviewing, --VerenaLauterbach CureVacAG (talk) 12:49, 8 May 2018 (UTC)[reply]

Reply 08-MAY-2018

  1. "Entering into collaboration" is a vague assertion which leaves out salient details like the purpose for the collaboration, and why. The text may be placed within the article without clarification, however, a vague inline template would be added along with it. Please advise if this is acceptable.
  2. Text within the article was found to be insufficiently paraphrased from the source material, and has been removed, per: WP:CLOSEPARAPHRASE. A listing of the text may be found here.
  3. Additional text was found to be insuffciently paraphrased from the source material. This text was integral to the lead section and the beginning of the main body of text, so it was not removed. A listing of that text may be found here. in lieu of this removal, the close paraphrasing maintenance template was appended to the article.

When ready to proceed with your response to point No. 1 above, kindly change the request edit template to read from ans=yes to ans=no. Thank you! .spintendo) 13:42, 8 May 2018 (UTC)[reply]


Dear Spintendo,
Thank you for working on the article. Since other collaborations are now no longer included in the history part, Eli Lilly does not have to be included there either. However, it would still make sense in the list of partners at the beginning - would you then still need further details or add the vague inline template if it is just listed? I could provide them, if necessary.
How can I help to improve the article in order to discard the close paraphrasing and verification templates if I am not allowed to work in the article because of my COI? I would be grateful for advice.
--VerenaLauterbach CureVacAG (talk) 14:42, 8 May 2018 (UTC)[reply]